SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Global Health informs about disclosure

20 Feb 2025 Evaluate

In furtherance, to its earlier intimation dated January 13, 2025, in respect of Scheme of Amalgamation between Medanta Holdings (MHPL), a wholly-owned subsidiary of the Company and Global Health (GHL/Company) and their respective Members and Creditors, under the provisions of Sections 230 to 232 of the Companies Act, 2013 (‘Scheme’), Global Health has informed that today the Scheme has been approved by the Hon'ble National Company Law Tribunal (NCLT) and that the final order is yet to be uploaded on the Hon’ble NCLT website. The Scheme will come into effect once the certified copy of above order from the Hon’ble NCLT is filed with the respective Registrar of Companies by the Transferor Company and Transferee Company.

The above information is a part of company’s filings submitted to BSE.

Global Health Share Price

1060.95 -4.25 (-0.40%)
13-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×